|
Arteris, Inc.
Condensed Consolidated Balance Sheets (In thousands, except share and per share data) (Unaudited) | ||||||||
| As of | ||||||||
|
September 30,
2024 |
December 31,
2023 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 17,829 | $ | 13,696 | ||||
| Short-term investments | 30,840 | 27,477 | ||||||
| Accounts receivable, net of allowance of $93 as of both September 30, 2024 and December 31, 2023 | 8,715 | 12,003 | ||||||
| Prepaid expenses and other current assets | 5,396 | 5,254 | ||||||
| Total current assets | 62,780 | 58,430 | ||||||
| Property and equipment, net | 4,058 | 5,745 | ||||||
| Long-term investments | 5,839 | 11,802 | ||||||
| Equity method investment | 6,436 | 8,500 | ||||||
| Operating lease right-of-use assets | 4,070 | 4,289 | ||||||
| Intangibles, net | 3,245 | 3,858 | ||||||
| Goodwill | 4,178 | 4,178 | ||||||
| Other assets | 7,109 | 5,999 | ||||||
| TOTAL ASSETS | $ | 97,715 | $ | 102,801 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 141 | $ | 183 | ||||
| Accrued expenses and other current liabilities | 12,966 | 11,831 | ||||||
| Operating lease liabilities, current | 948 | 781 | ||||||
| Deferred revenue, current | 38,991 | 31,537 | ||||||
| Vendor financing arrangements, current | 1,172 | 2,070 | ||||||
| Total current liabilities | 54,218 | 46,402 | ||||||
| Deferred revenue, noncurrent | 26,511 | 25,172 | ||||||
| Operating lease liabilities, noncurrent | 3,332 | 3,610 | ||||||
| Vendor financing arrangements, noncurrent | 669 | 1,292 | ||||||
| Deferred income, noncurrent | 7,928 | 8,810 | ||||||
| Other liabilities | 2,848 | 2,412 | ||||||
| Total liabilities | 95,506 | 87,698 | ||||||
| Stockholders' equity: | ||||||||
| Preferred stock, par value of $0.001 - 10,000,000 shares authorized as of both September 30, 2024 and December 31, 2023; no shares issued and outstanding as of both September 30, 2024 and December 31, 2023 | — | — | ||||||
| Common stock, par value of $0.001 - 300,000,000 shares authorized as of both September 30, 2024 and December 31, 2023; 40,127,476 and 37,518,583 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively | 40 | 37 | ||||||
| Additional paid-in capital | 130,678 | 118,193 | ||||||
| Accumulated other comprehensive income | 172 | 120 | ||||||
| Accumulated deficit | (128,681 | ) | (103,247 | ) | ||||
| Total stockholders' equity | 2,209 | 15,103 | ||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 97,715 | $ | 102,801 | ||||
